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PI3K in ANCA
Anti-neutrophil cytoplasmic autoantibod-
ies (ANCA) are associated with necrotiz-
ing crescentic glomerulonephritis and 
systemic vasculitis, in large part because 
of invading neutrophils. To investigate the 
signaling pathway used by neutrophils, 
Schreiber et al. transplanted bone mar-
row from mice that were deficient in phos-
phoinositol 3 kinase-γ (PI3Kγ) and then 
induced crescentic glomerulonephritis 
by injection of myeloperoxidase into 
myeloperoxidase-deficient mice. When 
wild-type bone marrow was infused into 
these mice, they developed the disease. 
However, bone marrow derived from 
mice that were deficient in PI3Kγ were 
protected from the glomerulonephritis. 
Similarly, treatment of the mice infused 
with wild-type bone marrow with an 
inhibitor of PI3Kγ prevented the develop-
ment of the nephritis as well. These studies 
identify an important target for develop-
ment of new therapies. Given that this 
molecule is under intense investigation by 
a number of pharmaceutical companies, 
the results of this preclinical study should 
inject some hope into the future of thera-
peutics for this very serious renal disease. 
See page 118.
Hydrogen water
Oxidative damage is one of the major 
pathogenic mechanisms in a number of 
diseases, especially fibrotic and inflam-
matory ones. Chronic allograft nephrop-
athy is one such disease. As they report 
in this issue, Cardinal et al. have tried a 
new thera peutic strategy to combat oxida-
tive damage in which they use molecular 
hydrogen, a reagent that can scavenge 
reactive oxygen species. Using a transplan-
tation model from one rat strain to another 
(with bilateral nephrectomy), they fed the 
animals water that had been bubbled with 
hydrogen gas. When rats were fed unhy-
drogenated water for 150 days, they devel-
oped proteinuria, and the graft eventually 
failed. But those rats ingesting hydrogen 
water had improved survival, fewer inflam-
matory mediators, and less activation of 
inflammatory pathways. If these results 
can be transplanted to humans, they might 
provide an effective and cheap therapy. 
See page 101.
Calcineurin and  
renin secretion
Renin secretion from the juxtaglomerular 
apparatus (JGA) is regulated by calcium 
in a manner that is opposite of the classic 
hormone secretion paradigm. Increases 
in cell calcium inhibit renin release. As 
they report in this issue, Madsen et al. 
studied the details of the mechanism 
using whole-cell patch clamp studies in 
which they measured the capacitance of 
the membrane as an index of exocytosis, 
since an increase in capacitance is due 
largely to increases in membrane area. 
They found that inhibition of calcineurin 
by cyclosporin stimulated renin secre-
tion. Calcineurin is a calcium-dependent 
phosphatase whose activity is depend-
ent on calcium/calmodulin levels in 
the cell. Similarly, intracellular delivery 
of a calcineurin inhibitor peptide pro-
duced the same effect as cyclosporin. 
There are three genes for calcineurin A, 
and the JGA cells expressed only two of 
them: the β and γ isoforms but not the 
α isoform. Using mice with the β or α 
isoform deleted, the authors found that 
cyclosporin increased renin in mice with 
the γ isoform deleted, suggesting that the 
α isoform is the culprit for the effect of 
cyclosporin. See page 110.
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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